estrogen replacement therapy reduces the risk of colorectal cancer
There's increasing evidence that estrogen replacement therapy reduces the risk of colorectal cancer.
This benefit started showing up several years ago.
Now it seems that estrogen lowers the risk of colorectal cancer by about a third.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote